Authors: Naveen ., Md Saquib Shafique, Ajay Pal Singh
Certificate: View Certificate
Heart failure, a complicated clinical problem, presently affects a smaller number of persons globally. Early on, cardiac centres and hospitals rely significantly on ECG to assess and diagnose heart failure. The utilization of an electrocardiogram, also known as ECG, is widespread in the medical field. Detecting heart ailments at an early stage remains a crucial challenge in the healthcare industry. The focus of this paper is to introduce various machine learning technologies for the detailed analysis of heart ailment detection. First, a weighted version of Nave Bayes is employed to forecast cardiac problems. The alternate bone, according to This system is designed for the automatic and anatomical localization/discovery of ischemic heart complaints. The system utilizes two classifiers that are similar to support vector machine (SVM) and XGBoost with swish performance, respectively. The system analyzes the features of the frequency sphere, time sphere, and information proposition to accurately locate and detect ischemic heart complaints. The third bone is an automated detection system for heart failure based on a bettered SVM based on the duality optimisation approach that was previously studied. To support clinical decision-making, a Heart Complaint Prediction Model (HDPM) is utilized in a Clinical Decision Support System (CDSS). As a result, treating problems properly and avoiding significant consequences will be easy. In order to evaluate essential decision tree-type algorithms for honing the finesse of heart complaint opinion, this study employs XGBoost. Four types of machine knowledge (ML) models are examined in terms of perfection, delicacy, f1-measure, and recall as performance criteria.
A. Background & Significance
Heart disease is among the leading causes of death globally. Detecting and predicting heart disease at an early stage is crucial in preventing negative outcomes and enhancing patient outcomes. However, traditional diagnostic approaches can be expensive, invasive, and time-intensive. Machine learning (ML) techniques have shown promise in predicting heart disease and can aid in early detection and better management of heart disease.
B. Objectives of the study
The main aim of this research is to create and assess machine learning algorithms for the prediction of heart disease. The study focuses on the following specific objectives:
C. Summary of the techniques employed:
The study will involve the following methods:
II. LITERATURE REVIEW
A. Overview of Heart Disease & their Causes
Coronary artery disease, heart failure, arrhythmias, and illnesses of the heart's valves are only a few of the several ailments referred to as "heart disease." Heart disease is associated with a number of prevalent risk factors, including high blood pressure, high cholesterol levels, smoking, diabetes, and a family history of the disease.
B. Previous studies on Heart Disease Prediction using ML Techniques
Several studies have explored the use of machine learning techniques for heart disease prediction for example a study by Cho et al. (2018) used a deep learning model to predict heart disease risk factors from ECG data. Another study by Alizadehsani et al. (2013) used decision trees and neural networks to predict heart disease risk factors from demographic and clinical data.
C. Strengths & Limitations of Previous Studies
The strength of previous studies on heart disease prediction using machine learning techniques include their ability to handle large amounts of data, identify complex patterns, and provide accurate predictions. However, some limitations of previous studies include the lack of standardized data sets, limited clinical interpretability of other models, and potential biases in the data.
D. Research Gaps & the Need for Further Investigation
There are several study gaps and a need for more research despite the encouraging findings of earlier studies. For example, most studies have focused on predicting heart disease risk factors rather than predicting actual heart disease outcomes. More standardized data sets are also required in order to assess the effectiveness of various ML algorithms. There is also a need to develop models that are more clinically interpretable and can be integrated into clinical decision-making. Finally, there is a need to evaluate the performance of the models in diverse populations and in real- world clinical settings.
A. Description of the Dataset Used
The study will use a publicly available data set such as the Cleveland Clinic Foundation’s Heart Disease Dataset or the Framingham Heart Study Dataset. These datasets contain a range of clinical and demographic features of patients with and without heart disease such as age, gender, blood pressure, cholesterol levels, and ECG data.
B. Data Cleaning & Preparation
The dataset will be preprocessed to remove missing values, handle outliers, and normalize the data. The preprocessing steps may include:
C. Feature Selection & Engineering
Feature selection techniques will be used to identify the most important features for heart disease prediction. The study will use techniques such as:
The study will also explore feature engineering techniques to create new features that may improve the performance of the models. Feature engineering techniques may include:
a. Transforming Variables: Transforming variables such as agents into groups or creating interaction terms between variables.
b. Domain Knowledge: Incorporating domain knowledge into the feature engineering process to create more informative features.
c. Dimensionally Reduction: To minimise the dimensionality of the data, approaches such as the use of PCA or t-distributed randomised neighbour embedding (t-SNE) are used.
A. Performing Metrics of the Models Used:
The study will use several performance metrics to elevate the performance of the models for heart disease prediction such as:
One of the performance metrics that will be utilized is the area under the receiver operating characteristic (ROC) curve, which measures the discrimination power of the classification model.
B. Comparison of the Models
The study will compare the performance of the different machine learning models used for heart disease prediction, such as logistic regression, decision trees, random forests, SVM, and ANN. The comparison will be based on the performance metrics described above, as well as the computational complexity and interpretability of the models.
C. Interpretation of the Results
The study will interpret the results of the models to gain insights into the factors that contribute to heart disease prediction. The primary interpretation involves:
The study will also discuss the limitations and potential biases of the models and suggests directions for future research to address these issues.
V. RESULTS & DISCUSSION
A. Description of the Machine Learning Techniques Used:
To predict heart disease, the study will employ a range of machine learning methods, such as logistic regression, decision trees, random forest, support vector machine (SVM), and artificial neural networks (ANN). These techniques will be implemented using popular ML libraries such as sci-kit Learn and TensorFlow.
B. Model Selection & Training
To divide the dataset into training and testing sets, the study will utilize either a train-test split or cross-validation technique. The training set will be utilized to develop the models, while the testing set will be used to evaluate their performance. Additionally, the study will explore other methods such as K-fold cross-validation and stratified sampling to enhance the reliability and generalizability of the models.
C. Hyperparameter Tuning
To modify the models' hyperparameters, the study will employ approaches such as grid search and randomised search. The hyperparameters, which include parameters like the learning rate or the number of hidden layers in an artificial neural network (ANN), are established before the training process and play a key role in determining the behavior of the models. Optimizing the hyperparameters will enhance performance metrics like precision, recall, accuracy, and F1 score.
Common performance measures such as accuracy, recall, F1 score, and area under the receiver operating characteristic (ROC) curve will be utilized to evaluate the models' performance. The ROC curve graphically depicts the trade- off between the true positive rate (TPR) and false positive rate (FPR) for different classification thresholds. The study will also use techniques such as confusion matrices and feature importance plots to gain insights into the performance and interpretability of the models.
VI. IMPLICATIONS, CONTRIBUTIONS, LIMITATIONS, AND FUTURE DIRECTIONS:
VII. SUMMARY & RECOMMENDATIONS
The study's main goal is to assess the effectiveness of various machine learning models in predicting heart disease and to gain insights into the contributing factors that influence the prediction. The study uses a dataset of patients with various clinical and demographic features and applies advanced techniques such as hyperparameter tuning and feature selection to optimize the performance of the models. The study evaluates the models based on performance metrics such as accuracy, precision, recall, F1 score, and area under the ROC curve and interprets the result to gain insights into the factors that contribute to heart disease prediction. The study makes several contributions to the field of cardiology and machine learning and suggests several directions for future research.
Based on the findings and limitations of the study, the following recommendations are suggested for future research:
 Soni J, Ansari U, Sharma D & Soni S (2011). Predictive data mining for medical diagnosis: an overview of heart disease prediction. International Journal of Computer Applications, 17(8), 43-8  Dangare C S & Apte S S (2012). Improved study of heart disease prediction system using data mining classification techniques. International Journal of Computer Applications, 47(10), 44-8.  Ordonez C (2006). Association rule discovery with the train and test approach for heart disease prediction. IEEE Transactions on Information Technology in Biomedicine, 10(2), 334-43.  Shinde R, Arjun S, Patil P & Waghmare J (2015). An intelligent heart disease prediction system using k-means clustering and the Naïve Bayes algorithm. International Journal of Computer Science and Information Technologies, 6(1), 637-9.  Bashir S, Qamar U & Javed M Y (2014, November). An ensemble-based decision support framework for intelligent heart disease diagnosis. In International Conference on Information Society (i-Society 2014) (pp. 259-64). IEEE.  Jee S H, Jang Y, Oh D J, Oh B H, Lee S H, Park S W & Yun Y D (2014). A coronary heart disease prediction model: the Korean Heart Study. BMJ open, 4(5), e005025.  Ganna A, Magnusson P K, Pedersen N L, de Faire U, Reilly M, Ärnlöv J & Ingelsson E (2013). Multilocus genetic risk scores for coronary heart disease prediction. Arteriosclerosis, thrombosis, and vascular biology, 33(9), 2267-72.  Jabbar M A, Deekshatulu B L & Chandra P (2013, March). Heart disease prediction using lazy associative classification. In 2013 International Mutli-Conference on Automation, Computing, Communication, Control and Compressed Sensing (iMac4s) (pp. 40- 6). IEEE.  Dangare Chaitrali S and Sulabha S Apte. \"Improved study of heart disease prediction system using data mining classification techniques.\" International Journal of Computer Applications 47.10 (2012): 44-8.  Soni Jyoti. \"Predictive data mining for medical diagnosis: An overview of heart disease prediction.\" International Journal of Computer Applications 17.8 (2011): 43-8.  Chen A H, Huang S Y, Hong P S, Cheng C H & Lin E J (2011, September). HDPS: Heart disease prediction system. In 2011 Computing in Cardiology (pp. 557-60). IEEE.  Parthiban, Latha and R Subramanian. \"Intelligent heart disease prediction system using CANFIS and genetic algorithm.\" International Journal of Biological, Biomedical and Medical Sciences 3.3 (2008).  Wolgast G, Ehrenborg C, Israelsson A, Helander J, Johansson E & Manefjord H (2016). Wireless body area network for heart attack detection [Education Corner]. IEEE Antennas and propagation magazine, 58(5), 84-92.  Patel S & Chauhan Y (2014). Heart attack detection and medical attention using motion sensing device -Kinect. International Journal of Scientific and Research Publications, 4(1), 1-4.  Zhang Y, Fogoros R, Thompson J, Kenknight B H, Pederson M J, Patangay A & Mazar S T (2011). U.S. Patent No. 8,014,863. Washington, DC: U.S. Patent and Trademark Office.  Raihan M, Mondal S, More A, Sagor M O F, Sikder G, Majumder M A & Ghosh K (2016, December). Smartphone-based ischemic heart disease (heart attack) risk prediction using clinical data and data mining approaches, a prototype design. In 2016 19th International Conference on Computer and Information Technology (ICCIT) (pp. 299-303). IEEE.  Buechler K F & McPherson P H (1999). U.S. Patent No. 5,947,124. Washington, DC: U.S. Patent and Trademark Office.  Takci H (2018). Improvement of heart attack prediction by the feature selection methods. Turkish Journal of Electrical Engineering & Computer Sciences, 26(1), 1- 10.  Worthen W J, Evans S M, Winter S C & Balding D (2002). U.S. Patent No. 6,432, 124. Washington, DC: U.S. Patent and Trademark Office.  Acharya U R, Fujita H, Oh S L, Hagiwara Y, Tan J H & Adam M (2017). Application of deep convolutional neural network for automated detection of myocardial infarction using ECG signals. Information Sciences, 415, 190-8.  Brown N, Young T, Gray D, Skene A M & Hampton J R (1997). Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ, 315(7101), 159-64.  Piller L B, Davis B R, Cutler J A, Cushman W C, Wright J T, Williamson J D & Haywood L J (2002). Validation of heart failure events in the Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants assigned to doxazosin and chlorthalidone. Current controlled trials in cardiovascular medicine, 3(1), 10.  Folsom A R, Prineas R J, Kaye S A & Soler J T (1989). Body fat distribution and self-reported prevalence of hypertension, heart attack, and other heart diseases in older women. International journal of epidemiology, 18(2), 361-7.  Kiyasu J Y (1982). U.S. Patent No. 4,338,396. Washington, DC: U.S. Patent and Trademark Office
Copyright © 2023 Naveen ., Md Saquib Shafique, Ajay Pal Singh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.